| 查看: 210 | 回复: 0 | |||
| 当前主题已经存档。 | |||
lw1966hhh铁杆木虫 (著名写手)
|
[交流]
研究一下路透社对小日本药物市场的分析《Jp Pharm Companies Outlook》
|
||
|
The Japanese Pharmaceutical Companies Outlook: An analysis of key players and growth strategies evaluates the strengths and weaknesses of the top 10 Japanese pharmaceutical firms' strategic and financial positions, marketed portfolios and pipeline compounds. This report will enable you to assess the market dynamics within the Japanese pharma market and understand how companies are positioning themselves at a time of significant change in their domestic market. The Japanese pharmaceutical market is the second largest in the world, behind only the US, with estimated sales of $52bn in 2002. While it makes it an attractive target for Western companies' expansion plans, low market growth (1% in 2002) has made the operating environment increasingly difficult for domestic players. Coupled with ongoing regulatory reforms and drug price cuts, which are largely intended to reduce the government's healthcare bill, Japanese companies are being forced to adapt their operating strategies. http://rapidshare.de/files/28238 ... es_Outlook_2004.pdf |
回复此楼» 猜你喜欢
锦州医科大学药用生物材料（专业代码1007Z1）招收调剂考生
已经有0人回复
-
锦州医科大学药用生物材料（专业代码1007Z1）招收调剂考生
已经有2人回复
-
药理学论文润色/翻译怎么收费?
已经有288人回复
-
中国医药行业发展现状：标准品推动药品检测水平提升
已经有1人回复
-
26申博自荐
已经有12人回复
-
标准品的纯度对于药品质量的影响有多大？
已经有0人回复
-
如何制备符合技术要求的药品标准品？
已经有0人回复
-
对照品在药品研发中的不可或缺性
已经有0人回复
-
标准品的分类和用途，你知道多少？
已经有0人回复
-
SUES&NERCN课题组接受硕士生调剂 (学硕1名+专硕1名)
已经有0人回复
